Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Immunosuppressive and Cytotoxic Therapy for Pulmonary Sarcoidosis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434284/0/Infliximab_for_the_treatment_of_rheumatoid_arthritis_Edited__no_change_to_conclusions_. Accessed 28 March 2024.
Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434284/0/Infliximab_for_the_treatment_of_rheumatoid_arthritis_Edited__no_change_to_conclusions_. Accessed March 28, 2024.
Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434284/0/Infliximab_for_the_treatment_of_rheumatoid_arthritis_Edited__no_change_to_conclusions_
Immunosuppressive and Cytotoxic Therapy for Pulmonary Sarcoidosis [Internet]. In: Cochrane Abstracts. [cited 2024 March 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434284/0/Infliximab_for_the_treatment_of_rheumatoid_arthritis_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis
ID - 434284
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434284/0/Infliximab_for_the_treatment_of_rheumatoid_arthritis_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -